Is renal biopsy always necessary to start immunosuppressive therapy in lupus nephritis?
Objective: Most of the patients with proliferative lupus nephritis (LN) have high titer of anti-dsDNA antibody and low complement levels. In this study, we tried to predict proliferative LN with serological profile. Methods: This prospective study was conducted in fifty pateints with known systemic...
Main Authors: | Vasudevan Chelliah, V Balaraman, S Ilango, S Ramesh, V Kannan Bhaba, D Shivakumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=12;epage=16;aulast=Chelliah |
Similar Items
-
The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
by: Ole Petter Rekvig
Published: (2019-05-01) -
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
by: Huixia Wang, et al.
Published: (2019-12-01) -
Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis
by: Daniele Faria Miguel, et al.
Published: (2020-02-01) -
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems
by: Hsieh SC, et al.
Published: (2016-09-01) -
Clinical significance of anti-C1q antibodies in SLE
by: Stiborová Ivana, et al.
Published: (2015-12-01)